Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways and intervention therapies in sepsis
Yunyu Zhang, Botao Ning
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
Hao Zhang, Yanghanzhao Wang, Mengdi Qu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 157
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney
Qiaohui Chen, Yayun Nan, Yuqi Yang, et al.
Bioactive Materials (2022) Vol. 22, pp. 141-167
Open Access | Times Cited: 82
GPX4, ferroptosis, and diseases
Wangzheqi Zhang, Yang Liu, Liao Yan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116512-116512
Open Access | Times Cited: 51
Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification
Dan Wu, Yuxin Shi, Hao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 49
Novel tripeptide RKH derived fromAkkermansia muciniphilaprotects against lethal sepsis
Shihao Xie, Jiaxin Li, Fengyuan Lyu, et al.
Gut (2023) Vol. 73, Iss. 1, pp. 78-91
Closed Access | Times Cited: 44
Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
Min Wang, Jun Feng, Daixing Zhou, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 43
Surviving Sepsis Campaign Research Priorities 2023
Daniel De Backer, Clifford S. Deutschman, Judith Hellman, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 2, pp. 268-296
Open Access | Times Cited: 37
Mitochondrial quality control in human health and disease
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Neutrophil extracellular traps in homeostasis and disease
Han Wang, Susan J. Kim, Lei Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Suppression of Lipopolysaccharide‐Induced Sepsis by Tetrahedral Framework Nucleic Acid Loaded with Quercetin
Zhiqiang Liu, Xingyu Chen, Wen‐Juan Ma, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 43
Closed Access | Times Cited: 51
Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
Xiran Lou, Jinfang Xue, Ruifei Shao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 36
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms
A. M. Marques, Carla Torre, Rui Pinto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2892-2892
Open Access | Times Cited: 32
Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
Huikang Xu, Shiying Sheng, Weiwei Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
The pathogenesis and potential therapeutic targets in sepsis
Wendan Zhang, Honghong Jiang, Gaosong Wu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 31
The role and mechanisms of gram-negative bacterial outer membrane vesicles in inflammatory diseases
Shuoling Chen, Lei Qian, Xianghui Zou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
The role of neutrophil extracellular traps in sepsis and sepsis-related acute lung injury
Shujing Zou, Hongyu Jie, Xinai Han, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110436-110436
Closed Access | Times Cited: 29
Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions
Anna Stierschneider, Christoph Wiesner
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
IRF3 function and immunological gaps in sepsis
Bristy Basak, Sachiko Akashi‐Takamura
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
CD5L as a promising biological therapeutic for treating sepsis
Liliana Oliveira, Marisela Silva, Ana Gomes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Activation of senescence in critically ill patients: mechanisms, consequences and therapeutic opportunities
Paula Martín-Vicente, Cecilia López‐Martínez, Beatriz Rioseras, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
Jialian Wang, Xingyu Tao, Zhengyang Liu, et al.
Pharmacological Research (2025) Vol. 212, pp. 107596-107596
Open Access | Times Cited: 1
Necroptosis, Pyroptosis, Ferroptosis in Sepsis and Treatment
Mengdi Qu, Yanghanzhao Wang, Zhiyun Qiu, et al.
Shock (2022) Vol. 57, Iss. 6, pp. 161-171
Closed Access | Times Cited: 29
Tetrahedral framework nucleic acid nanomaterials reduce the inflammatory damage in sepsis by inhibiting pyroptosis
Xingyu Chen, Jiajun He, Yu Xie, et al.
Cell Proliferation (2023) Vol. 56, Iss. 8
Open Access | Times Cited: 21
Human peripheral blood mononuclear cells as a valuable source of disease‐related biomarkers: Evidence from comparative proteomics studies
Michal Alexovič, Csilla Uličná, Ján Sabó, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2023) Vol. 18, Iss. 2
Closed Access | Times Cited: 21
The Effect of CytoSorb on Inflammatory Markers in Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials*
Marc Heymann, Raoul Schorer, Alessandro Putzu
Critical Care Medicine (2023) Vol. 51, Iss. 12, pp. 1659-1673
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top